(Q46794117)

25 December 2017

title

Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patients (English)

1 reference

25 December 2017

1 reference

1 reference

1

1 reference

25 December 2017

Joseph J Eron

4

object named as

Joseph J Eron

1 reference

25 December 2017

author name string

Barbara A da Silva

2

1 reference

25 December 2017

Charles B Hicks

3

1 reference

25 December 2017

Roy M Gulick

5

1 reference

25 December 2017

Melanie A Thompson

6

1 reference

25 December 2017

Florence McMillan

7

1 reference

25 December 2017

Martin S King

8

1 reference

25 December 2017

George J Hanna

9

1 reference

25 December 2017

Scott C Brun

10

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

published in

HIV Clinical Trials

1 reference

25 December 2017

volume

9

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

1-10

1 reference

25 December 2017

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

cites work

1 reference

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

21 January 2018

1 reference

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

21 January 2018

1 reference

Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection

21 January 2018

1 reference

Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial

21 January 2018

1 reference

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial

21 January 2018

1 reference

Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus

21 January 2018

1 reference

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients

21 January 2018

1 reference

Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.

21 January 2018

1 reference

Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures

21 January 2018

1 reference

96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures

21 January 2018

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.

21 January 2018

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

Evolution of lipid abnormalities in patients switched from stavudine- to tenofovir-containing regimens

21 January 2018

1 reference

Improvement of dyslipidemia in patients switching from stavudine to tenofovir: preliminary results

21 January 2018

1 reference

Short communication: benefits in the lipid profile after substitution of abacavir for Stavudine: a 48-week prospective study

21 January 2018

1 reference

Progression of lipodystrophy (LD) with continued thymidine analogue usage: long-term follow-up from a randomized clinical trial (the PIILR study).

21 January 2018

1 reference

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study

21 January 2018

1 reference

Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team

21 January 2018

1 reference

Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir

21 January 2018

1 reference

The assessment of insulin resistance in man.

21 January 2018

1 reference

Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans

21 January 2018

1 reference

Adiponectin: action, regulation and association to insulin sensitivity

21 January 2018

1 reference

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin

21 January 2018

1 reference

Leptin: structure, function and biology

21 January 2018

1 reference

Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1310/HCT0901-1

1 reference

25 December 2017

1 reference

25 December 2017